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Abstract
Background: Astragalus fascicolifolius manna is used to treat different diseases. Because pregnant women tend to use
Astragalus. fascicolifolius and Iranian traditional medicine emphasizes the abortifacient potential of this plant, this
study aimed to investigate Astragalus fascicolifolius manna abortifacient property and effects on estrogen, progesterone,
LH and FSH levels in BALB/c mice.
Method: This experimental study was conducted with 70 female BALB/c mice assigned to seven groups: Nonpregnant,
untreated; nonpregnant, Astragalus. fascicolifolius extract (400 mg/kg)-treated; pregnant, Astragalus. fascicolifolius
extract (400, 800 and 1200 mg/kg)-treated; and two pregnant control groups. On 18 and 19 days of pregnancy, cesarean
section performed on mice, resorbed embryos counted; then Follicle-stimulating hormone (FSH), Luteinizing hormone
(LH), estrogen and progesterone levels were measured by the ELISA.
Results: Astragalus. fascicolifolius extract caused a significant increase abortion in mice. The levels of progesterone,
FSH and LH were significantly different among the groups such that mean progesterone level was lower and mean LH
and FSH levels were higher in the Astragalus. fascicolifolius extract-treated groups than the pregnant, untreated group.
Conclusion: This extract has abortifacient properties and this plant can be used cautiously in pregnancy. Decreasing
progesterone, increasing FSH and LH feedback in response to decreased progesterone by this extract is one of the po-
tential mechanisms involved in abortion.
Keywords: Astragalus fascicolifolius manna, estrogen, progesterone, FSH, LH
1. Introduction
A bortion refers to the spontaneous ordeliberate ending of a pregnancy before
the fetus has evolved sufficiently to survive.
Overall, abortion is the termination of pregnancy
before 20 weeks of pregnancy [1-3]. The causes of
abortion include embryonic factors including
chromosomal abnormalities and abnormal evo-
lution of the zygote, and maternal factors
including uterine anatomical abnormalities,
immunological factors, coagulation disorders,
endocrine factors, infections, environmental fac-
tors, physical trauma and cervical failure [4].
Induced abortion is the deliberate termination of
pregnancy using medical or surgical procedures
before the embryo can survive. The techniques
for abortion can be surgical or medical proced-
ures. Surgical techniques include dilatation and
curettage, dilatation and discharging, dilatation
and withdrawal, menstrual aspiration and lapa-
rotomy. In medical techniques, three drugs con-
sisting of antiprogestin mifepristone,
antimetabolite methotrexate, and prostaglandin
misoprostol are used. These medications cause
abortion through increasing uterine contractility
[5].
In pregnancy, certain changes occur in the secre-
tion of hormones. Gonadotropin-releasing hormone
(GnRH) is released from syncytial trophoblasts to
Received 27 November 2019; accepted 5 December 2019.
Available online 1 December 2020.
* Corresponding author at: Shahrekord University of Medical Sciences, Shahrekord, Iran. Fax: þ98 383 3330709.
E-mail address: zahralorigooini@gmail.Com (Z. Lorigooini).
https://doi.org/10.37796/2211-8039.1113














the mother's body fluids. The most important action
of this hormone is to prevent the corpus luteum
from regression at the end of the menstrual cycle. In
pregnancy, the first estrogen is secreted from the
corpus luteum and, after placental growth; it is
secreted from the placenta. In late pregnancy, es-
trogen to progesterone ratio increases, which is
responsible for increased uterine contractility and
the progression of the delivery process. Progester-
one is essential for the progression of pregnancy,
and during pregnancy, it is first secreted from the
corpus luteum and then the placenta [6].
Medicinal plants have been commonly used in
Iran and other countries since ancient times. The
use of medicinal plants has changed greatly at
different times depending on the time requirements
[7, 8]. In recent years, the use of medicinal plants has
increased sharply[9, 10]. Most pregnant women as-
sume that nature-based medications do not lead to
any drug interaction for fetal and maternal and
therefore turn to self-medication with them, while
they may cause certain fetal and maternal side ef-
fects or drug interactions [11, 12]. To consider that,
A. fascicolifolius manna is used to treat different
diseases and may pregnant women consume it to
treat the problems during pregnancy [13], and to
attention that traditional medicine emphasizes the
abortifacient potential of this plant and therefore
discourages pregnant women from eating it, the
effect of A. fascicolifolius manna investigated on the
abortifacient creation. A. fascicolifolius manna as a
byproduct is the result of the activity of an insect in
the order Coleoptera on these shrubs. According to
traditional medicine, this plant has several proper-
ties including an earache- and joint pain-relieving
and skin patch and wart treating [14-16]. A. fas-
cicolifolius manna contains glycosides, saponins and
alkaloids [13, 17]. Because certain changes occur in
the levels of estrogen, progesterone LH and FSH in
pregnancy and abortion, and A. fascicolifolius may
contribute to induced abortion through influencing
the levels of these hormones, this study was con-
ducted to aim determining abortifacient A. fas-
cicolifolius manna hydroalcoholic extract effect on
estrogen, progesterone, LH and FSH levels in
BALB/c mice [18, 19].
2. Materials and methods
2.1. Preparation of manna extract
A. fascicolifolius manna samples were collected
from the heights of Geno, Hormozgan province,
with an altitude of 300 m, and botanically identified
as A. fascicolifolius manna and assigned the
herbarium no. 721 at the Medical Plants Research
Center of Shahrekord University of Medical Sci-
ences (SKUMS). The samples were dried and then
pulverized. Extraction was conducted with 50%
ethanol. The resulting extract was filtered with
Whatman filter paper grade 1. Then, the concen-
trated extract was incubated at 37C to dry.
2.2. Determining total saponin content of the
extract
First, 100 mg of the plant powder was mixed with
10 ml of distilled water and then finely stirred for
30 seconds. The formation of persistent foam
30 minutes later was considered to represent the
presence of saponin. To determine saponin content,
25 g of the plant powder was extracted using 250 ml
of 50% ethanol under reflux for 3 hours. The mixture
was filtered by a Whatman filter paper grade 2 and
concentrated under vacuum. The resulting aqueous
extract was extracted three times with equal
amounts of n-butanol. Afterward, the n-butanol
phase was decanted and concentrated by a rotary
evaporator under vacuum. The residue was freeze-
dried and its weight considered total saponin con-
tent [20].
2.3. Determination of total phenolic and flavonoid
content of the extract
The total phenolic content of the extract was
assayed by the FolineCiocalteu method. The total
flavonoid content in A. fasciculifolius extract was
determined using the aluminium chloride colouri-
metric method. Total phenolic and total flavonoid
content was calculated from the calibration curve,
and the results were expressed as mg of gallic acid
equivalent per g dry weight and as mg rutin
equivalent per g dry weight, respectively [21].
2.4. Determination of antioxidant capacity of the
extract
The antioxidant activity of A. fasciculifolius extract
was determined by 1, 1-diphenyl-2-picrylhydrazyl
(DPPH) free radical scavenging assay. The percent
inhibition of DPPH free radicals was calculated from
(A control-A sample/Control)  100, where Ablank
is the absorbance of the control reaction, and A
sample is the absorbance of the solution in the
presence of plant extract. The concentration causing
50% inhibition of DPPH free radicals (IC50) was
calculated from the regression equation for the
concentration of extract and percentage inhibition
[22].
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The protocol of this experimental study conforms
to the Guide for the Care and Use of Laboratory
Animal and the ethical guidelines of the SKUMS
Bioethics Committee (approval no.: IR.SKUMS.-
REC.1394.231). In this study, a total of 70 female
BALB/c mice aged 8-12 weeks and weighing 25-30g
were housed at (21 ± 2) C and 12-h light/dark cycle
as they had free access to the same food and water.
The mice were assigned to seven groups of equal
numbers as follows:
Group 1: Nonpregnant untreated; group 2:
Nonpregnant A. fascicolifolius manna extract
(400 mg/kg)-treated; Groups 3-5: Pregnant, A. fas-
cicolifolius manna extract (400, 800 and 1200 mg/kg)-
treated (The extract was intraperitoneally adminis-
tered on 7-14 days); group 6: Pregnant, distilled
water treated; and group 7: Pregnant, untreated.
Because the pregnancy period in mouse is
21 days, on days 18 and 19 of pregnancy blood
samples were collected from hearts according to the
ethical guidelines under general anesthesia and
serum levels of estrogen, progesterone, LH and FSH
measured by the ELISA. Then, the cesarian section
was performed on the mice; their beaded fallopian
tubes (Fig. 1) removed and then resorbed fetuses in
these tubes, representing the number of aborted
fetuses, counted [23].
2.6. Measuring FSH, LH, Progesterone and
Estrogen level in serum
After the blood samples were collected from the
hearts, they were transferred to microtubes and
serum samples isolated by centrifuging. Then, the
serum levels of estrogen, progesterone, FSH and LH
were measured by a standard ELISA kit (Shang-
haicristal Day Biotech Co., China). First, standard
solution was diluted and then 40 ʎ of each serum
sample was added to the ELISA kit wells. Then, 10 ʎ
of the specific antibodies of the serum parameters
and 50 Landa of streptavidin solution was added to
the wells. The ELISA kit was incubated at 37C for
1 hour and then the wells emptied. The washing
solution was diluted to 1.30 and 200 ʎ of the result-
ing washing solution added to each well in tripli-
cate. Then, 50 ʎ of chromogen a solution and 50 ʎ of
chromogen B solution were added to the wells and
then the ELISA kit incubated at 37C for 10 minutes.
Finally, a stop solution was added to the wells. Then,
the ELISA kit was placed into an ELISA reader to
yield the data prints.
2.7. Statistical Analyses
The normal distribution of data was investigated
by the Shapiro-Wilks test. Data were presented as
mean ± SD (standard deviation) for normally
distributed variables and as median (IQR: inter-
quartile range) for non-normal distributed vari-
ables. ANOVA followed by the least significant
difference (LSD) was used to compare the normally
distributed variables between the groups and the
Kruskal-Wallis test followed by Dunn's test to
compare the non-normally distributed variables
between the groups. Statistical significance was
defined as P < 0.05 and analysis was performed by
SPSS version 23.
3. Results
3.1. Phytochemical contents of the extract
The saponin content of the dried plant (25 g) was
approximately 32 ± 2 %w/w. The total phenolic
content was 36.35 ± 1.58 mg of gallic acid equivalent
per g dry weight while the content of flavonoids was
negligible. The antioxidant capacity of A. fas-
ciculifolius extract by DPPH method was determined
and the IC50 value of the extract was found to be
223.57 ± 10.07 mg/ml.
3.2. Effect of A. fascicolifolius manna extract on
FSH and Progesterone
The levels of FSH increased significantly in the
pregnant extract (400, 800 and 1200 mg/kg)-treated
groups compared to the pregnant untreated group
(p < 0.001), but this increase was not significant in
the nonpregnant extract (400 mg/kg)-treated group
compared to the nonpregnant untreated group
(p > 0.05). The progesterone level decreased signif-
icantly in the pregnant extract (400, 800 andFig. 1. Beaded fallopian tubes (the photo was taken by author).
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1200 mg/kg)-treated groups compared to the preg-
nant untreated group (p < 0.001), but this hormone
decrease was not significant in the nonpregnant
extract (400 mg/kg)-treated group compared to the
nonpregnant untreated group (p > 0.05) (Table 1).
3.3. Effect of A. fascicolifolius manna extract on
LH, and Estrogen Level and abortion percentage
Abortion percentage was significantly different
between the pregnant extract (400, 800 and 1200 mg/
kg)-treated groups and the pregnant untreated
group (p < 0.01), but not between the distilled water
treated and pregnant untreated groups (p > 0.05). LH
level increased significantly in the pregnant extract
(400, 800 and 1200 mg/kg)-treated groups compared
to the pregnant untreated group (p < 0.001), but this
increase was not significant in the nonpregnant
extract (400 mg/kg)-treated group compared to the
nonpregnant untreated group (p < 0.05). Estrogen
level was not significantly different between the
pregnant extract (400, 800 and 1200 mg/kg)-treated
groups compared to the pregnant untreated group
as well as between the nonpregnant extract (400 mg/
kg)-treated group and the nonpregnant untreated
group (p > 0.05) (Table 2).
4. Discussion
Studies have indicated that women tend to
consume herbal drugs because it is commonly
believed that herbal drugs have many benefits and
are not harmful to the body; therefore, most people
are willing to use medicinal herbs, rather than
chemical drugs, to cure diseases [24, 25]. Most
pregnant women assume that nature-based drugs
cause no drug interactions, fetal, and maternal side
effects and therefore turn to self-medication with
them [26]. Around 205 million pregnancies occur
each year worldwide, over one-third of which is
unplanned. Around one-fifth of these pregnancies
lead to intentional abortion. Most intentional non-
therapeutic abortions are due to unplanned preg-
nancies [1]. The intentional abortion has a long
history and has been performed using various
techniques such as the abortifacient herbs and the
use of sharp implements and other traditional
methods [27, 28].
Therapeutic intentional abortion occurs if there
are maternal or fetal indications [29]. Abortion can
occur spontaneously, which is called unintentional
abortion [30]. One of the environmental causes of
unintentional abortions is the use of medicinal
plants such as A. fascicolifolius manna. To the best of
our knowledge, no study has yet been conducted to
investigate the abortifacient property of A. fas-
cicolifolius manna. In the current study, we observed
a significant difference in abortion percentage be-
tween the groups treated with A. fascicolifolius
manna extract at 400, 800 and 1200 mg/kg and the
pregnant untreated group and the abortion per-
centage increased with increasing the extract dose.
The current study also showed that A. fascicolifolius
manna extract probably could cause abortion.
Besides that, progesterone level decreased and
FSH and LH levels increased significantly in the
pregnant extract-treated groups compared to the
pregnant untreated group; although A. fascicolifolius
manna extract caused an increase in estrogen, this
increase was not statistically significant. Because the
progesterone level in the pregnant A. fascicolifolius
manna extract-treated groups decreased signifi-
cantly compared to the pregnant untreated group,
and progesterone is required for maintaining
pregnancy and implantation, and its reduction leads
to a decrease in fetal growth and resorption, then
probably decrease in progesterone level can be one
of the mechanisms of significant increase in abor-
tion in the extract-treated groups.
Table 1. Effects of A. fascicolifolius manna on FSH and Progesterone in the different groups.
Variable
Groups
FSH (pmol/l) Progesterone (pmol/l)
M ± SD M ± SD
Nonpregnant untreated 12/267 ± 0/567 11/668 ± 0/311
Nonpregnant extract (400 mg/kg)-treated 13/304 ± 0/705 11/530 ± 0/277
Pregnant extract (400 mg/kg)-treated 11/117 ± 0/398 16/240 ± 0/503
Pregnant extract (800 mg/kg)-treated 11/400 ± 0/303 15/963 ± 0/452
Pregnant extract (1200 mg/kg)-treated 0/545 ± 11/485 15/761 ± 0/189
Pregnant distilled water treated 0/212 ± 12/200 10/660 ± 0/151
Pregnant untreated 0/216a ± 10/266 16/906 ± 0/441b
Signification(P) 0/001 0/001
a Significant difference in FSH level compared to Astragalus fascicolifolius manna extract (400, 800 and 1200 mg/ml)-treated, distilled
water treated and nonpregnant untreated groups ( p < 0.001).
b Significant difference in progesterone level compared to A. fascicolifolius Manna extract (400, 800 and 1200 mg/ml)-treated, distilled
water treated and nonpregnant untreated groups ( p < 0.001).
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The compounds of A. fascicolifolius manna have
not yet been fully and precisely identified, but
phytochemical investigations on other mannas have
confirmed the presence of compounds as well as
saponin and alkaloids, and quantitative studies
should also be conducted to precisely detect and
isolate the compounds of A. fascicolifolius manna [13,
31]. Some alkaloids, such as berberine in barberry
fruit, pass easily into organic cations of the cell
membrane and form a complex with the DNA
molecule and cause structural changes in it, which
leads to a change in the regulatory activities of the
genes as well as impairments in the differentiation
pathways [32]. Recent Studies on antimicrobial and
antineoplastic effects of alkaloids have demon-
strated that these compounds inhibit oxygen supply
by the cell, and oxygen uptake complete inhibit
causes cell death and stops or restricts fetal growth
[33, 34]. Studies have been demonstrated that
saponin exerts abortifacient, anti-zygote and anti-
implantation properties [35]. This compound can
also exert teratogenic effects and therefore cause
abortion or fetal death in rabbit and mouse [36].
Besides that, the study of Dollahite et al. showed
that saponin could increase uterine contractions
[37]. The phytochemical investigations in the pre-
sent study demonstrated the significant and
acceptable amount of total saponin in A. fas-
cicolifolius manna extract, contrary to lack of phenol
and flavonoid in the extract. Fetal resorption can be
attributed to the anti-fetus effects of the alkaloid and
saponin present in A. fascicolifolius manna. In this
study, there was no significant difference in abortion
percentage between the distilled water treated and
control group and therefore the stress due to taking
mice and the extract administration did not
contribute to increased abortion.
Our results showed that the progesterone level
decreased significantly and dose-dependently in the
pregnant treated groups with A. fascicolifolius
manna extract compared to the pregnant untreated
group. It has been reported that alkaloids inhibit the
activity of aromatase (the key enzyme in the syn-
thesis of steroids) and thus reduce the synthesis of
steroid hormones, including progesterone [38]. Also,
saponin decreases the secretion of progesterone by
reducing cholesterol, an essential ingredient for
steroid hormone synthesis [39].
The alkaloid and saponin in A. fascicolifolius
manna can be one of the mechanisms of a sig-
nificant decrease in progesterone level in the
pregnant mice treated with its extract. The estro-
gen level in the pregnant treated groups with A.
fascicolifolius manna at different doses increased
compared to the pregnant untreated group in a
dose-dependent response yet insignificantly.
Probably, the abortifacient effects of this extract
may be due to different mechanisms from those
leading to changes in estrogen levels. The levels
of FSH and LH increased significantly in the
pregnant treated groups with A. fascicolifolius
manna at different doses compared to the preg-
nant untreated group, with the highest FSH and
LH levels observed in the pregnant group
receiving this extract at 1200 mg/kg. Probably,
decreased the level of progesterone in the treated
group with this manna extract is likely to stimu-
late the secretion of GnRH from the hypothala-
mus through negative feedback, which in turn
stimulates the synthesis of pituitary gonadotro-
pins [40, 41].
The changes in the levels of estrogen, progester-
one, FSH and LH in the nonpregnant mice treated
with A. fascicolifolius manna extract to compare with
Table 2. Effects of A. fascicolifolius manna on LH and estrogen levels and abortion percentage in the different groups.
Variable
Groups
LH (pmol/l) (pmol/l) estrogen abortion percentage
Med (IQR) Med (IQR) Med (IQR)
Nonpregnant untreated 2/950 (2/800-3/050) 28/960 (28/300-30/125)
Nonpregnant extract (400 mg/kg)-treated 3/015 (2/890-3/275) 32/650 (30/122-30/125)
Pregnant extract (400 mg/kg)-treated 4/610 (4/575-4/667) 35/875 (35/550-36/325) 0/190 (0/097-0/200)
Pregnant extract (800 mg/kg)-treated 4/500 (4/460-5/070) 39/150 (38/050-41/250) 0/236 (0/200-0/279)
Pregnant extract (1200 mg/kg)-treated 4/700 (4/640-5/560) 40/600 (39/000-41/700) 0/300 (0/250-0/400)
Pregnant distilled water treated 2/950 (2/145-3/300) 35/500 (34/650-35/650) 0/000 (0/000-0/091)
Pregnant untreated 2/300 (1/975-2/340)a 36/150 (35/250-36/375)b 0/000 (0/000-0/016)c
Signification (P) 0/001 0/001 0/001
a Significant difference in LH level compared to Astragalus fascicolifolius manna extract (400, 800 and 1200 mg/ml)-treated and
nonpregnant untreated groups ( p < 0.001).
b Significant difference in estrogen level compared to A. fascicolifolius manna extract (400, 800 and 1200 mg/ml)-treated groups
( p < 0.01).
c Significant difference in abortion percentage compared to A. fascicolifolius manna extract (400, 800 and 1200 mg/ml)-treated groups
( p < 0.01).
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the nonpregnant untreated mice were similar to
pregnant mice; more clearly, progesterone level
decreased and estrogen, FSH and LH levels
increased in the mice receiving A. fascicolifolius
manna extract yet insignificantly. These insignifi-
cant hormonal changes in the nonpregnant A. fas-
cicolifolius manna extract-treated mice can be
attributed to the lower sensitivity of estrogen- and
progesterone-secreting cells in the ovary compared
to that of placental syncytial trophoblasts to A. fas-
cicolifolius manna compounds. Therefore, it is
necessary to conduct additional studies to investi-
gate the effects of A. fascicolifolius manna extract at
higher doses on the levels of progesterone, estrogen,
FSH and LH in nonpregnant mice.
Regarding the significant percentage of abortion
in the mice receiving A. fascicolifolius manna extract,
we can argue that probably this A. fascicolifolius
manna has an abortifacient effect and this abortion
increase due to decreased progesterone level. The
presence of certain compounds such as saponin and
alkaloids in this extract may be the cause of the
decrease in progesterone levels. This argument
needs further investigation. Pregnant women are
recommended to consume this plant more
cautiously. A. fascicolifolius manna can also be used
to induce abortion in women with indications for
therapeutic abortion.
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